You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!Submit Review
Potent and selective Nav1.6 channel blocker (IC50 values are 7.8, 341, 988, 1260, 1270, 78500 and >30000 nM for Nav1.6, Nav1.3, Nav1.4, Nav1.2, Nav1.7, Nav1.5 and Nav1.8). Derivative of tetrodotoxin (Cat. No. 1078).
|Storage||Store at -20°C|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
|Solvent||Max Conc. mg/mL||Max Conc. mM|
Preparing Stock Solutions
The following data is based on the product molecular weight 301.25. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|0.04 mM||82.99 mL||414.94 mL||829.88 mL|
|0.2 mM||16.6 mL||82.99 mL||165.98 mL|
|0.4 mM||8.3 mL||41.49 mL||82.99 mL|
|2 mM||1.66 mL||8.3 mL||16.6 mL|
References are publications that support the biological activity of the product.
Rosker et al (2007) The TTX metabolite 4,9-anhydro-TTX is a highly specific blocker of the Nav1.6 voltage-dependent sodium channel. Am.J.Physiol.Cell Physiol. 293 C783 PMID: 17522141
Hargus et al (2013) Evidence for a role of Nav1.6 in facilitating increases in neuronal hyperexcitability during epileptogenesis J.Neurophysiol 110 1144 PMID: 23741036
If you know of a relevant reference for 4,9-Anhydrotetrodotoxin, please let us know.
View Related Products by Product Action
Keywords: 4,9-Anhydrotetrodotoxin, 4,9-Anhydrotetrodotoxin supplier, Na+, channel, blockers, Sodium, Nav, 1.6, channels, voltage-gated, voltage-dependent, potent, selective, 4,9-anhydro-TTX, Voltage-gated, Channels, 6159, Tocris Bioscience
Citations for 4,9-Anhydrotetrodotoxin
Citations are publications that use Tocris products.
Currently there are no citations for 4,9-Anhydrotetrodotoxin. Do you know of a great paper that uses 4,9-Anhydrotetrodotoxin from Tocris? Please let us know.
Reviews for 4,9-Anhydrotetrodotoxin
There are currently no reviews for this product. Be the first to review 4,9-Anhydrotetrodotoxin and earn rewards!
Have you used 4,9-Anhydrotetrodotoxin?
Submit a review and receive an Amazon gift card.
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Literature in this Area
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* or download your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
Epilepsy is a brain disease that affects 60 million people globally. More than 20 anti-seizure drugs are currently available, but these do not address the underlying causes of the condition. This poster summarizes current knowledge about the development of the condition and highlights some approaches that have disease-modifying effects in proof-of-concept studies.